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Abstract
Delirium is an acute, severe neuropsychiatric syndrome, characterized by cognitive deficits, that is highly prevalent in aging and dementia and
is frequently precipitated by peripheral infections. Delirium is poorly understood and the lack of biologically relevant animal models has limited
basic research. Here we hypothesized that synaptic loss and accompanying microglial priming during chronic neurodegeneration in the ME7 mouse
model of prion disease predisposes these animals to acute dysfunction in the region of prior pathology upon systemic inflammatory activation.
Lipopolysaccharide (LPS; 100 g/kg) induced acute and transient working memory deficits in ME7 animals on a novel T-maze task, but did not
do so in normal animals. LPS-treated ME7 animals showed heightened and prolonged transcription of inflammatory mediators in the central
nervous system (CNS), compared with LPS-treated normal animals, despite having equivalent levels of circulating cytokines. The demonstration
that prior synaptic loss and microglial priming are predisposing factors for acute cognitive impairments induced by systemic inflammation suggests
an important animal model with which to study aspects of delirium during dementia.
© 2012 Elsevier Inc.
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Delirium is an acute and transient impairment of global
cognitive function, causing marked impairments in con-
sciousness, attention, immediate recall, orientation (tem-
poral and spatial), and perception (Burns et al., 2004;
Meagher, 2009). It is highly prevalent in the aged and
demented population and it is now well accepted that epi-
sodes of delirium hasten cognitive and functional decline
and increase mortality (Fick et al., 2002; MacLullich et al.,
2009; McCusker et al., 2001; Murray et al., 1993; Pitkala et
al., 2005; Rahkonen et al., 2000; Rockwood et al., 1999).
Recent high profile studies have reiterated this with a spe-
cific focus on patients with Alzheimer’s disease (Fong et al.,
* Corresponding author at: Trinity College Dublin, School of Biochem-
istry and Immunology, Lloyd Building, Dublin, Ireland. Tel.: 353 1
8968528.E-mail address: colm.cunningham@tcd.ie (C. Cunningham).
0197-4580 © 2012 Elsevier Inc.
doi:10.1016/j.neurobiolaging.2010.04.002
Open access under CC BY license.2009b). Despite these important economic and medical im-
peratives, delirium is understudied and poorly understood
(Fong et al., 2009a). One reason for this is the lack of
biologically relevant animal models.
It is well accepted that systemic inflammation, caused by
infection, surgery, or injury can induce episodes of delirium
in elderly or demented patients (Beloosesky et al., 2007;
Elie et al., 1998; Lemstra et al., 2008; Lerner et al., 1997;
van Munster et al., 2008) while much less commonly caus-
ing similar dysfunction in younger or nondemented patients.
The mechanisms of this dysfunction remain unclear. We
have previously shown that microglia, the major macro-
phage population of the brain, are primed by prior neuro-
degenerative pathology to respond more robustly to sys-
temic inflammatory signals (Cunningham et al., 2005).
Here, we hypothesized that systemic inflammation, induced
in animals with early stage neurodegeneration (ME7 prion
disease), characterized by synaptic loss and primed micro-
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transient working memory dysfunction that is not induced
by similar challenges in normal animals. In previous studies
we reported a systemic inflammation-induced learning def-
icit in a reference memory task (Cunningham et al., 2009a)
but novel approaches were necessary to investigate whether
prior hippocampal pathology would be sufficient to predis-
pose animals to systemic inflammation-induced working
memory deficits that were acute onset and transient. These
are key criteria in the clinical diagnosis of delirium.
ME7 is a prion disease strain that has been mouse-
adapted and constitutes a real progressing neurodegenera-
tive disease, characterized by extracellular amyloidosis,
synaptic loss, robust neurodegeneration, and progressive
cognitive decline (Betmouni et al., 1999; Cunningham et al.,
2003). Because the early pathology is chiefly hippocampal,
disease-associated cognitive impairments consist of failure on
spatial working and reference memory tasks that, in the mouse,
are hippocampal-dependent. We predicted that acute systemic
inflammation would induce hippocampal-dependent working
memory impairments at a time when such impairments were
not yet present in disease per se. Because systemic inflamma-
tion causes changes in appetite, locomotor activity, motivation,
and stress, which can confound many commonly used tests of
hippocampal function in mice (Cunningham and Sanderson,
2008), we have designed and validated a novel shallow water
T-maze alternation task that is less sensitive to these confound-
ing factors. We challenged prion-diseased (ME7) and normal
mice, at 12 weeks postinoculation, with bacterial endotoxin at
100 g/kg and analyzed the acute effects (3–8 hours) on
working memory. We also assessed learning in an egocentric
Y-maze task to assess the generality of performance deficits. In
order to assess the degree of, and possible mechanisms under-
pinning, the primed brain’s heightened responses to systemic
inflammation, we examined a number of inflammatory recep-
tors and assessed the time course of expression of systemic and
central nervous system (CNS) cytokines and effector mole-
cules. Our findings suggest a model system that will be im-
portant in delineating the systemic and central inflammatory
contributions to acute cognitive dysfunction, as seen in delir-
ium.
2. Methods
2.1. Animals and stereotaxic surgery
Female C57BL/6 mice at 8–10 weeks of age (Harlan
Olac Ltd, Bicester, United Kingdom) were housed in cages
of 5 at 21 °C with a 12 : 12 hour light-dark cycle with food
and water ad libitum. They were anesthetized with intraper-
itoneal Avertin (Sigma, Poole, UK) and stereotactically
injected with 1 l of a 10% w/v scrapie (ME7 strain)-
nfected C57BL/6 brain homogenate (or 10% w/v normal
rain homogenate (NBH): at bregma: anterior-posterior
2.5 mm, lateral 1.7 mm, depth 1.6 mm) using a
amilton microsyringe (Sigma, Poole, UK). Additional an-mals (n  8) were injected intracerebrally (4 injections
ilaterally) with N-methyl-D-aspartic acid (NMDA; 10 mg/
L) to ablate the hippocampus under isoflurane anesthesia
approximately 2%) with perisurgical analgesia (carprophen
mg/kg). Chlordiazepoxide (CDZP; 10 mg/kg) and atro-
ine (0.075 mg/kg) were given to minimize seizure activity
nd bronchial secretions respectively. In all other respects
he hippocampal lesions were performed as previously de-
cribed (Deacon et al., 2002). Sham-operated animals (n 
2) had 8 holes drilled in the skull, but no intracerebral
njections were made. All animal procedures were done in
trict accordance with UK Home Office license and Irish
epartment of Health regulations.
.2. Intraperitoneal challenges
Experimental groups with ME7 or NBH at 12 weeks
ostinoculation were injected intraperitoneally (i.p.) with
00 g/kg (or 200 g/kg to age-matched naive mice) of
ipopolysaccharide (LPS; equine abortus, Sigma L5886,
oole, UK) in a volume of 200 l saline. This dose mimics
a mild infection, producing small changes ( 1 °C) in core
body temperature. Controls were administered 200 l non-
pyrogenic saline in each case.
2.3. T-maze alternation: working memory
We assessed hippocampal-dependent working memory
(3–8 hours post-LPS) using alternation behavior in a novel
“escape from shallow water” T-maze task to allow assess-
ment of performance in animals experiencing sickness be-
havior. The T-maze was constructed of black Perspex with
dimensions (cm): long axis 67, short axis 38, depth 20, and
arm width 7. There was a single 40 mm diameter hole at the
end of each choice arm, 2 cm from the floor. Black exit
tubes were inserted into these holes (these may also be
blocked to prevent exit). A “guillotine” door was inserted to
prevent access to 1 or other choice arm. This maze was
filled with water at 20 °C to a depth of 2 cm to motivate
mice to leave the maze by “paddling” or walking “on
tip-toe” to an exit tube. Animals were taken with their cage
mates to a holding cage. Each mouse was placed in the start
arm of the maze with 1 arm blocked such that they were
forced to make a left (or right) turn, selected in a pseudoran-
dom sequence (equal numbers of left and right turns, no more
than 2 consecutive runs to the same arm). On making this turn
the mouse could escape from the water by entering the small
tube, and then a transit tube, in which it was carried to another
holding cage. The mouse was held here for 25 seconds (intra-
trial interval) during which time the guillotine door was re-
moved and the exit tube was switched to the alternate arm. The
mouse was then replaced in the start arm and could choose
either arm. The mouse must alternate from its original turn to
escape. On choosing correctly mice escape to the transit tube as
before and are returned to their home cage. On choosing
incorrectly the mice were allowed to self-correct to find the
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605C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616correct exit arm. Validation of this task is shown in supple-
mentary data (Figure S1).
2.4. Y-maze egocentric reference memory
The egocentric Y-maze was identical to that used in a
previous study (Cunningham et al., 2009a) with the excep-
tion that it was surrounded with black plastic material to a
height of 1 meter such that visual cues were negated as
completely as possible (as opposed to the use of visual cues
in the allocentric version). Mice were placed in the start arm
and both this arm and the exit arm were fixed for any given
animal. The animal, thus, had to learn the correct body turn
to exit the maze. The start arm/exit arms were counterbal-
anced across groups. ME7 or NBH-injected mice, with or
without LPS were placed in this maze 3 hours posttreatment
for 12 trials and the numbers of incorrect trials were re-
corded. Probe trials were conducted to confirm egocentric
strategy.
2.5. Tissue processing, ELISA, quantitative PCR and
immunohistochemistry
ME7 and NBH animals were perfused with heparinized
saline at 12 weeks postinoculation and at 1, 2, 4, and 8 hours
post-LPS/saline for enzyme-linked immunosorbent assay
(ELISA) (Cunningham et al., 2007) and polymerase chain
reaction (PCR). We have previously published methods for
ribonucleic acid (RNA) isolation, complementary DNA
Table 1
Mouse Taqman primer and probe sequences
Target Oligonucleotide Sequence
D68 Forward primer 5=-CAAGG
Reverse primer 5=-CCAAA
Probe 5=-CGGTA
PAR Forward primer 5=-TGCAA
Reverse primer 5=-TGGGC
Probe 5=-CCCTC
LR4 Forward primer 5=-GGCTC
Reverse primer 5=-TCTGA
Probe 5=-CATGG
L-1R1 Forward primer 5=-GCAAT
Reverse primer 5=-ATCAT
Probe 5=-TCCTG
FNAR2 Forward primer 5=-GAGAG
Reverse primer 5=-TCGCA
Probe 5=-TGCAC
rem2 Forward primer TGTGGTC
Reverse primer CTCCGGG
Probe CCAAGA
RF7 Forward primer CGAGGA
Reverse primer TACATGA
Probe CCAGCTC
D200R1 Forward primer AGGAGG
Reverse primer TGCCTCC
NF R p55 Forward primer GCTGACC
Reverse primer GCCATCC
CAM-1 Forward primer GATGTAA
Reverse primer GATGGC
here probe is not included, Sybr green has been used in its place.(cDNA) synthesis, and quantitative PCR, as well as primerand probe sequences for many genes examined here (Cun-
ningham et al., 2005, 2007, 2009a, 2009b; Palin et al.,
2008). Further primer and probe sequences are shown in
Table 1. Additional animals were perfused with 10% for-
malin and paraffin wax-embedded for immunohistochemis-
try. Sections were labeled with antibodies against synap-
tophysin (Sy38, Millipore, Dublin, IRL), IBA-1 (Abcam,
Cambridge, United Kingdom), and IL-1 (PeproTech, Lon-
on, United Kingdom) as described in previous publications
Cunningham et al., 2003, 2005, 2009a). Briefly, nonspe-
ific peroxidase activity was eliminated by incubating sec-
ions in 1 mL H2O2/100 mL methanol (1% H2O2) for 10
minutes before antigen retrieval was carried out by micro-
waving in citrate buffer (pH 6) for 2  5 minutes (IBA-1,
L-1) or by heating in boric acid (pH 9) for 30 minutes at
60 degrees (Sy38). After washing, sections were blocked
with normal sera and incubated overnight with primary
antibodies at 1/200 (IBA-1), 1/50 (IL-1) and 1/2000
(Sy38). Labeling was completed using the appropriate bio-
tinylated secondary antibody, ABC complex and diamino-
benzidine (DAB) as chromagen before hematoxylin coun-
terstaining. In the case of Sy38, nickel DAB was used in the
place of DAB to produce a more intense, black stain and
these slides were not counterstained.
2.6. Statistical analyses
Behavioral data were compared by repeated measures
Amplicon size (bp)
GGGAGGTTGTG-3= 75
AGCTGTCCATAAGGA-3=
TCCCCACCTGTCTCTCTC-3=
GCTATCCTACA-3= 116
GGGAAGACT-3=
GCACAGAAAGGAGCTTGAA-3=
CTAGGACTCTGA-3= 114
TGCATTGGTAGGT-3=
GTTCTTCTCCTGCCTGA-3=
GGTCACACGAGTA-3= 117
CCTGGGTCAGCTT-3=
CTCGGAATGAGACGATC-3=
AAAACGGACTTAAGAG-3= 98
CCACAAGACACA-3=
TCTGCCGTCGG-3=
GGCTGGACT 68
GTGAGGA
GGCACCAACTTCAG
ATGCAGCAT 108
CACATCCAGGAA
CGAGCGCAGC
ATGCAGCCTTA 80
TAGTCACAGTATC
GCTCTACGAA 132
CAGCATACA
AAAAGAACATAACAAGAAC 90
TTACCAAGGAAGATCCA
GGTA
CCCA
TGCC
ATCC
CAGA
CTGG
TCCA
CACT
ATCC
TGAT
AGCC
CAGA
GACA
CGTC
AGAG
TCCA
TGCTG
ACCCT
TGGT
TCAC
ATGAA
ACCT
CTCT
ACCA
AAGG
AGGTAanalysis of variance (ANOVA) with Bonferroni posthoc
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606 C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616tests performed after any significant main effect. Significant
interactions were further investigated with analysis of sim-
ple main effects. Percentage correct trials on Y-maze ac-
quisition were compared by repeated measures ANOVA to
assess acquisition across 2 blocks of trials. Comparisons of
transcription in ME7 versus NBH animals were performed
by Student t test. Analysis of temporal patterns of gene
transcription was assessed by 2-way ANOVA comparing
ME7LPS with NBHLPS with posthoc tests at selected
time points.
3. Results
3.1. The primed hippocampus: synaptic loss and
inflammatory receptors
We assessed synaptic loss in the hippocampus of ME7
animals. Presynaptic terminals are extremely numerous in
the CA1 and when labeled by anti-synaptophysin antibody
the strata appear as distinct layers of granular staining of
relatively uniform density. In the stratum radiatum of nor-
mal animals (rad) the dendrites of the CA1 pyramidal neu-
Fig. 1. Hippocampal vulnerability: synaptic loss and inflammatory primi
stratum lacunosum moleculare (lac) of the hippocampus, visualized by i
espectively) and ME7 animals at 12 weeks postinoculation (b and d, 20
ame region of NBH (e) and ME7 animals (f), labeled using anti-IBA-1 a
he inflammatory receptors TLR4, IL-1R1, TNFR p55, and IFNAR2, mi
REM2 and CD200R in ME7 and NBH animals at 12 weeks. Significant*** (p  0.001). n  9, ME7; and n  4, NBH. Scale bar  100 m in a androns (pyr) can be seen as fine lines that remain unstained by
this antibody (Fig. 1a and c). ME7 animals, at 12 weeks
postinoculation, showed significant synaptic loss in the stra-
tum radiatum of the hippocampal CA1 pyramidal cell layer
compared with NBH animals at the same stage. This is most
easily seen as a decreased density of staining in the stratum
radiatum (rad) compared with relatively unchanged levels in
the stratum lacunosum moleculare (lac) (Fig. 1a–d). The
stratum radiatum also shows significantly increased micro-
glial activation, as visualized by IBA-1 labeling (Fig. 1e and
f). These IBA-1-positive cells are more numerous than in
NBH animals and also show a more condensed, less rami-
fied morphology.
We examined messenger RNA (mRNA) levels for a
number of inflammatory receptors that might underpin ele-
vated responses to the local or systemic synthesis of inflam-
matory mediators. The receptors toll-like receptor 4 (TLR4,
p 0.05), interleukin-1 receptor, type I (IL-1R1, p 0.05),
tumor necrosis factor receptor (TNFR, p 0.0001) p55 and
interferon receptor 2 (IFNAR2, p  0.005) all showed
ignificant elevation in ME7 animals compared with NBH
ynaptic terminals in the stratum oriens (so), stratum radiatum (rad) and
staining with sy38 anti-synaptophysin in NBH (a and c, 20 and 40,
40, respectively). Increased microglial numbers and activation state in the
against microglia and visualized at 20. (g) Hippocampal expression of
CD68 and uPAR and the myeloid-restricted anti-inflammatory markers
nces by Student t test are denoted by * (p  0.05), ** (p  0.0027), andng. Pres
mmuno
and 
ntibody
croglial
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607C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616animals when compared by Student t tests (Fig. 1g). That
microglia are activated is confirmed by the upregulation of
the phagocytic marker CD68 (p  0.0001) and the micro-
lial marker urokinase plasminogen activator receptor
uPAR, p  0.05) (Cunningham et al., 2009b). That the
egree of this activation is limited was indicated by the
ncreased expression of the myeloid-specific anti-inflamma-
ory markers triggering receptor expressed on myeloid cells
(TREM2) and CD200 receptor (CD200R) (p  0.0001).
Thus, the hippocampus is primed by loss of synapses and
increased microglial activation.
3.2. Acute and transient working memory deficit
ME7 and NBH animals were trained on a novel paddling
alternation T-maze task for 10 blocks of 10 trials. By the
end of training (24 hours before LPS or saline challenge) all
animals had reached a steady baseline performance at or
above 80% correct choices. Student t test of all ME7 ver-
us all NBH revealed that animals in the early stages of
E7-associated “dementia” (12 weeks) are not impaired
ith respect to controls (p  0.6976) while animals at 18
eeks postinoculation are significantly slower to learn the
ask (Supplementary data, Figure S1).
Systemic challenge with LPS (100 g/kg) did not induce
emory impairments in NBH animals. However the same
PS challenge induced a marked working memory deficit in
E7 animals (Fig. 2a). The memory performance of NBH
nd ME7 groups of animals were compared across all time
oints postinjection with LPS or saline (i.e., 3–26 hours)
sing ANOVA. Importantly, there was a significant group
NBH versus ME7) by drug treatment (saline versus LPS)
nteraction (F  9.94, df 1,43, p  0.005). Subsequent
nalysis of simple main effects confirmed that there was a
ignificant effect of LPS treatment in the ME7 group (F 
7.67, df 1,43, p  0.001), but not in the NBH group (F 
, p 0.80). Furthermore, there was a significant difference
etween the groups under the effects of LPS treatment (F
0.37, df 1,43, p  0.005), but not after a saline injection
F  1.70, df 1,43, p  0.20). As with most cases of
elirium, this deficit had an acute onset and was transient,
onsistent with a pharmacological rather than pathological
isturbance.
.3. Specificity of working maze deficits
Because LPS causes exaggerated sickness behavior in
rion-diseased mice with respect to NBH animals (Com-
rinck et al., 2002), it was important to verify that any
ognitive change observed was not attributable to some
PS-induced aspect of sickness that produced a nonspecific
ffect on performance. Parallel groups of animals were
ested in a reference memory Y-maze task, similar in its
otor and motivational components to the T-maze. NBH or
E7 animals, treated with LPS or saline, showed equivalent
earning (Fig. 2b), and probe trials showed that correct re-
ponding in this Y-maze task was not dependent on extramaze fiues (i.e., the task is egocentrically solved). Repeated measures
NOVA showed no difference between any of the experimen-
al groups, i.e., there was a main effect of block (F 27.01, df
1,43, p  0.0001), but no effect of treatment (F  0.34, df
3,43, p  0.79) and no interaction of group and block (F 
0.31, df 3,43, p 0.8187). Thus LPS does not impair learning
of this task in either ME7 or NBH animals.
We also examined the effect of LPS on T-maze working
memory at 200 g/kg to assess whether exaggerated inflam-
ation alone was sufficient to induce working memory
eficits. Naive animals were treated i.p. with saline or LPS
nd tested in the maze between 3 and 7 hours. Alternation
n the T-maze was maintained above 85% in both animal
roups (Fig. 2c). Two-way ANOVA revealed no effect of
reatment (F  0.25, df 1,16, p  0.62) or interaction of
treatment and time (F  0.38, df 2,32, p  0.68). Therefore
LPS does not affect working memory in normal animals
even at the higher dose of 200 g/kg.
Hippocampally-lesioned animals (HPC) and sham con-
trols were placed in the T-maze for blocks of 10 trials on 3
consecutive days (n  12 sham and 8 HPC; Fig. 2d).
Sham-operated animals show daily increases in percentage
alternation from initial chance levels while HPC animals
fail to improve their performance over 3 days of training.
Two-way ANOVA revealed a main effect of treatment (F
12.8, df 1,18, p  0.0021) and a significant interaction of
treatment and trial block (F  4.39, df 2,36, p  0.0197).
The task is therefore hippocampus-dependent. Typical hip-
pocampal lesions are shown in Fig. 2e.
3.4. Time course analysis of systemic and CNS
inflammation
Systemic challenge with LPS (100 g/kg) resulted
n robust increases in circulating cytokines. Circulating
NF-, IL-1 and IL-6 were below reliable detection levels
in all saline-treated animals, indicating that neurodegenera-
tion per se does not induce systemic cytokines. LPS induced
an increase in TNF- at 1 hour postinjection, with levels
ecreasing considerably thereafter (Fig. 3a), while IL-6
eaked at 2 hours and decreased markedly thereafter (Fig.
b) and IL-1 was induced at more modest levels, rising
radually up to 4 hours and decreasing by 8 hours (Fig. 3c).
PS had similar effects in NBH and ME7 animals. Two-way
NOVA revealed that there was no main effect of group for
ny cytokine (NBHLPS versus ME7LPS, F  2.22, df,
1,7, p  0.18) but there were interactions between treatment
and time post-LPS for all 3 cytokines (F  3.76, df 3,21, p 
0.05). Bonferroni posthoc tests revealed that ME7LPS was
actually significantly lower than NBHLPS for both TNF-
(p 0.01) and IL-1 (p 0.05) at 1 hour. Thus across the full
emporal profile of the major proinflammatory cytokines, ME7
nimals do not show elevated systemic inflammation with
espect to NBH animals similarly challenged.
Conversely, there were differences in the temporal pro-
le of cytokine transcription in the hippocampus of LPS-
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608 C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616Fig. 2. LPS-induced working memory deficits and validation of T-maze alternation. (a) Performance of ME7LPS (n  12), ME7saline (n  11),
NBHLPS (n  13) and NBHsaline (n  11) animals in the novel T-maze alternation task at baseline (22, 24 hours), posttreatment with saline
or LPS (3, 5, 7 hours) and upon recovery (24, 26 hours). Schematic representation of this T-maze is shown on right, illustrating forced entry to 1 arm
on the sample run and alternation on the choice run. Simple main effects analysis revealed an effect of LPS specifically in the ME7 group and this
is denoted by * (p  0.001). (b) Performance of similar groups in the egocentric Y-maze (shown on right), 3 hours posttreatment, assessed as 2 blocks
of 6 trials. Repeated measures analysis of variance (ANOVA) revealed no effect of treatment, but a main effect of block (denoted as *, p  0.0001).
n  15, ME7LPS; n  13, NBHLPS; n  9, ME7saline, and NBHsaline. (c) Performance of the T-maze alternation spatial working memory
ask (after training: 10 blocks of 10 trials) in normal C57BL6 mice treated with LPS 200 g/kg (n  9) or sterile saline (n  9). There were no effects
f treatment. (d) Training of hippocampal-lesioned (n  8) and sham-operated animals (n  12) on the spatial working memory T-maze task. A main
ffect of lesion group (p  0.0021) in a 2-way ANOVA analysis is denoted by *. (e) Cresyl violet-stained coronal sections from representative
ham-operated and hippocampal-lesioned animals.
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NBH animals (Fig. 3d–g). LPS induced equivalent tran-
scription of cytokines in ME7 and NBH animals at 1 hour,
but at 2 hours postchallenge, for all transcripts except IL-6,
levels decreased in NBHLPS animals but increased fur-
ther in ME7LPS animals. Repeated measures ANOVA
analysis of ME7LPS versus NBHLPS, using treatment
and time post-LPS as factors, revealed main effects of
treatment for IL-1, TNF-, and IFN- (F  9.94, 10 and
7.75 respectively, df 1,7 p  0.05 for all analyses). There
was also an interaction of time and treatment for IL-1,
TNF-, and IFN- (F 4.59, 3.13 and 4.04 respectively, df
,21, p  0.05). Bonferroni posthoc tests revealed that
Fig. 3. Comparison of systemic and hippocampal cytokine responses. Plas
posttreatment with LPS or saline and samples were analyzed for (a) TNF-
f NBHLPS versus ME7LPS revealed no effect of disease for any cyto
and time and significant pair-wise comparisons by Bonferroni posthoc are
(n  5). Saline-treated groups did not show detectable levels of these cyto
points by quantitative PCR. All genes were elevated after LPS treatment. M
2-way ANOVA. Statistical significance by Bonferroni posthoc tests after
0.001). n  5 for all ME7 groups and n  4 for all NBH groups.NF- (p  0.001), IL-1 (p  0.01), and IFN- (p  b0.05) were significantly higher in ME7LPS than in
NBHLPS animals at 2 hours and IL-1 (p  0.05) and
FN- (p 0.01) remained so at 4 hours, but no differences
ere present for any cytokine at 1 hour (p  0.05).
.5. Altered microglial phenotype in the absence of
orphological change
Histological sections showed microglial priming in the
ippocampus of ME7 animals as evidenced by increased
BA-1 positive cells with condensed, less ramified, morpho-
ogical appearance in this region (Fig. 4b and c). We de-
cribe these microglia as primed rather than activated
prepared from whole blood of NBH and ME7 animals 1, 2, 4, or 8 hours
-6, and (c) IL-1 protein levels. Two-way analysis of variance (ANOVA)
 2.22, df, 1,7, p  0.18). There were significant interactions of treatment
d by * (p  0.05) or ** (p  0.01). NBHLPS (n  4) and ME7LPS
 4–5). (d–g) CNS cytokine transcription was assessed at the same time
PS animals were compared with NBHLPS group by repeated measures,
cant main effect is denoted by * (p  0.05), ** (p  0.01), or *** (p ma was
, (b) IL
kine (F
denote
kines (n
E7L
a signifiecause they show this characteristic morphological ap-
at
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(Fig. 4g). LPS induces the synthesis of IL-1 by perivas-
cular and proximal parenchymal microglial cells in the
hippocampus and thalamus of ME7 animals (Fig. 4d–f)
without inducing significant morphological changes (Fig.
4b and c insets). IL-1 is not detectable either in ME7
animals challenged with saline or in NBH challenged with
LPS (Fig. 4g and h).
3.6. Responsive genes
We examined microglial markers and genes downstream
of both NF-B (LPS, IL-1, TNF- signaling) and Stat 1/2
(Type I interferon signaling) activation to confirm the ac-
tivity (and hence protein expression) of these inflammatory
cytokines. A number of these responsive genes were found
to be acutely and highly upregulated in animals treated with
LPS and these are illustrated in Fig. 5. Further LPS-induced
changes in expression of the inflammatory receptors as-
sessed in NBH and ME7 in Fig. 1 have also been assessed
but these are less dynamically altered by LPS and are shown
in supplementary data (Fig. S2).
The genes for monocyte chemoattractant protein 1
Fig. 4. Microglial priming and further activation. IBA-1 immunolabelling
changes in the hippocampus of ME7 animals (b) and ME7LPS anim
orphological changes can be seen in insets (a–c) (100). Immunos
erivascular and parenchymal IL-1-positive cells at 3 hours post-LPS in t
indicative of microglial cells (e; 100). IL-1 was not detected in ME7
and c, and 20 m in the insets. Scale bar (d) represents 100 m in (d) an(MCP-1) and inducible nitric oxide synthase (iNOS) bothshowed elevation at 1 hour and peaked at 2 hours (Fig. 5a
and b). Repeated measures ANOVA comparing NBHLPS
versus ME7LPS animals revealed no main effect of treat-
ment for MCP-1, but an interaction of treatment and time
(F  4.4, df 3,21, p  0.0149) with a significant difference
t 2 hours by Bonferroni posthoc test (p  0.05). For iNOS
here was a main effect of treatment (F  8.68, df 1,7, p 
0.0215).
Cox-2, which can be induced in both endothelial and
microglial cells, showed marked expression that was greater
in the ME7LPS group than in NBHLPS mice, but only
at later time points (Fig. 5c, main effect of treatment: F 
9.16, df 1,7, p  0.0192). The endothelial marker VCAM-1
was significantly induced at 1 hour, but this was not signif-
icantly different between ME7LPS and NBHLPS
groups: there was no effect of treatment (F  1.46, df 1,6,
p  0.2720) and no interaction between time and treatment
(F  1.35, df 3,18, p  0.2905) (Fig. 5d).
Conversely, NF-B-dependent PTX3 (Li et al., 2002) did
not begin to show elevation until 2 hours postchallenge and
peaked at 4 hours (Fig. 5e). This suggests that its transcrip-
tion is downstream of proinflammatory cytokines IL-1 and
n used to demonstrate increased numbers of microglia and morphological
compared with NBH animals (a) photographed at 20 magnification.
with anti-IL-1 antibody, photographed at 40 magnification, shows
ocampus (d) and the thalamus (f) of ME7LPS animals, with morphology
g) or in NBHLPS (h). Scale bar (a) represents 100 m in pictures a, b,
m in (f, g, and h) and 12.5 m in (e).has bee
als (c)
taining
he hipp
saline (TNF- because it does not show the rapid induction of other
pt
(
int in N
611C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616LPS-induced genes assessed. There was a main effect of
treatment (F 27.32, df 1,7, p 0.0012), with a significant
Fig. 5. Expression of transcripts for downstream or effector molecules. Exp
NF-kB-dependent (iNOS, MCP-1, PTX3, COX-2, VCAM-1), and stat 1/2
with LPS in NBH and ME7 animals and compared with ME7 or NBH anim
2-way analysis of variance (ANOVA) with treatment and time post-LPS a
Bonferroni posthoc tests, between ME7LPS and corresponding time poost-hoc comparison at 2 hours (p  0.01). Similarly bhe interferon-induced, stat 1/2-dependent transcript IRF7
Doyle et al., 2002) was clearly elevated at 4 hours but not
of microglial (uPAR, CD200R, COX-2), endothelial (VCAM-1, COX-2),
ent (IRF7) transcripts was examined at 1, 2, 4, and 8 hours postchallenge
ated with saline (4 hours). ME7LPS and NBHLPS were compared by
s. Main effects are described in the main text. Significant differences, by
BHLPS, are denoted by * (p  0.05), and ** (p  0.01).ression
depend
als tre
s factorefore this (Fig. 5f), consistent with its known induction
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reatment (F  36.23, 1,6, p  0.0009) with a significant
osthoc comparison at 4 hours (p  0.05).
Altered microglial activation status induced by systemic
hallenge was indicated by changes in myeloid-restricted
ene transcription: uPAR peaked at 2 hours and was higher
n ME7LPS than in NBHLPS (Fig. 5g). There was a
ignificant effect of treatment (F  19.44, df 1,7, p 
.0031), an interaction of time and treatment (F  3.94, df
,21, p  0.0225) and a significant posthoc difference at 2
ours (p  0.001). The mRNA levels of the myeloid-
estricted CD200R were markedly higher in ME7 animals
han in NBH and decreased with time post-LPS. There were
ain effects of treatment (F  61.89, df 1,25, p  0.0001)
nd of time (F  5.23, df 3,25, p  0.01). CD200R is
ignificantly decreased at 4 (p  0.01, Bonferroni posthoc
est; Fig. 5h) in ME7LPS with respect to saline controls.
. Discussion
In the current study we have shown for the first time that
cute systemic inflammation at clinically relevant levels
nduces working memory deficits in animals early in the
rogression of disease in a model of dementia, but does not
ause similar impairments in normal animals treated with
he same or greater doses of LPS. We have demonstrated
hat this working memory deficit is acute and transient:
hese mice perform well on the task before LPS challenge,
ake more errors under the influence of LPS, and return to
ood performance as the inflammatory event resolves. This
s distinct from previous reference learning deficits de-
cribed by us in this model (Cunningham et al., 2009a) and
rom deficits in a serial spatial reversal task in aged mice
reated with LPS (Chen et al., 2008). The deficits are
ssociated with pre-existing hippocampal synaptic loss
nd with microglial priming that includes elevated ex-
ression of a number of inflammatory receptors, thus
riming the brain to subsequent inflammatory insults.
espite equivalent systemic inflammatory responses,
E7 animals treated with LPS showed higher hippocam-
al transcription of proinflammatory cytokine genes than
ormal animals similarly treated.
.1. Inflammatory mechanisms of cognitive dysfunction
Systemic inflammation can produce affective and mild
ognitive changes in healthy individuals (Cohen et al.,
003; Krabbe et al., 2005; Reichenberg et al., 2001) and in
evere cases (i.e., sepsis/critical illness) this can trigger
elirium (Gunther et al., 2008). However, even mild to
oderate systemic inflammation can precipitate delirium in
ged and demented individuals. Immunotherapy with cyto-
ines can induce delirium (IL-2, IFN) (Adams et al., 1988;
erner et al., 1999; van Steijn et al., 2001) and increased
ystemic cytokines and acute phase proteins (IL-6, IL-8,
RP) are associated with delirium post hip fracture (Be- Noosesky et al., 2007; de Rooij et al., 2007; van Munster et
l., 2008). Significantly, delirium was associated with pre-
xisting cognitive impairment in these hip fracture studies.
hus, while elevated systemic cytokines, in particular IL-6,
re clearly a risk factor for delirium, and severity of acute
nsult is a predictor of delirium generally (Noimark, 2009),
rior cognitive impairment is a crucial cofactor and thus
re-existing pathology is likely to be the key risk factor. In
he current model we have made systemic challenges when
nimals already show synaptic loss and are on the cusp of
he appearance of impairments in cognition (Cunningham et
l., 2009a), and this model system thus allows detailed study
f the interaction between systemic inflammation and prior
egenerative changes.
Prior studies have shown that systemic infection with E.
oli or treatment with LPS (Pugh et al., 1998) produces
mpaired contextual fear conditioning in rodents and this is
ore robustly impaired in aged animals (Barrientos et al.,
006). These impairments (Hein et al., 2007) and others in
patial reference memory can be replicated by making direct
ntrahippocampal (Matsumoto et al., 2004) but not systemic
Thomson and Sutherland, 2005, 2006) challenges with
L-1, and those effects are dependent on prostaglandins. In
a more difficult serial spatial reversal task, in young mice,
LPS can produce IL-6-dependent impairments (Sparkman et
al., 2006) but those studies showing working memory
changes in aged versus younger animals have not yet de-
fined key molecules in this process (Chen et al., 2008). The
primed CNS/microglial response (Cunningham et al., 2005;
Perry et al., 2007) has been implicated in many of these
studies (Barrientos et al., 2006; Chen et al., 2008; Godbout
et al., 2005) but the nature of this priming remains little
investigated. We originally demonstrated that microglia
proximal to existing CNS pathology (i.e., synaptic and neu-
ronal loss and amyloid deposition) show morphological
evidence of activation but do not synthesize detectable
IL-1 protein, but upon systemic or central LPS challenges
hey display clear microglial IL-1 protein synthesis (Cun-
ingham et al., 2005). We proposed that this primed re-
ponse is not seen systemically because peripheral macro-
hages are not proximal to pathological changes such as
hose proximal to CNS microglia and indeed across the
ntire time course of LPS-induced systemic cytokine pro-
uction, systemic levels are never higher in ME7 animals
han in NBH animals. That these cytokines are initially
lightly higher in NBH animals than in ME7 may be ex-
lained by the reported elevated hypothalamic pituitary ad-
enal axis activation in prion-diseased rodents (Voigtlander
t al., 2006).
With respect to a possible molecular basis for the exag-
erated CNS responses to systemic inflammation we have
hown here that a number of key receptors for local re-
ponses to LPS and inflammatory cytokines are elevated in
he ME7 hippocampus (TLR4, IL-1RI, TNFR p55, IF-
AR2), and this may be significant in the priming of this
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required to examine the functional significance of these
transcriptional increases in inflammatory receptors.
The induction of cytokine transcripts in the current study
is equivalent in NBH and ME7 animals at 1 hour post-LPS
but levels increase at 2 hours in the ME7LPS group, while
decreasing in NBHLPS animals. The time course data are
consistent with initially equivalent transcription in the en-
dothelial cells followed by induction of these transcripts in
the primed microglia of ME7LPS animals but signifi-
cantly less transcription in NBHLPS microglia. Many
transcripts seem likely to be synthesized initially by the
endothelial cell layer: iNOS and MCP-1 show induction at
1 hour, similar to known endothelial products VCAM-1 and
Cox-2. Early expression of iNOS and MCP-1 cannot be
explained by NF-B-dependent transcription downstream
of CNS cytokine expression. Conversely, the time course of
expression indicates that PTX3 (Li et al., 2002) is tran-
scribed downstream of IL-1/TNF- and that IRF7 is tran-
cribed downstream of IFN-/ (Honda and Taniguchi,
006) and therefore these transcripts act as surrogate mark-
rs of the activity of IL-1/TNF- and IFN-/ respec-
tively. NF-B induction is necessary for the transcription of
many of these genes and may be the result of direct LPS
signaling at the endothelium. There is considerable evi-
dence that LPS can directly activate the endothelium in
inducing CNS responses (Chakravarty and Herkenham,
2005; Gosselin and Rivest, 2008) and it is detectable in the
blood within a short time of i.p. injection (Teeling, unpub-
lished). Moreover, the rapid CNS induction of IFN- is
dependent on IRF3 (Honda and Taniguchi, 2006) and is thus
induced by LPS but not by IL-1. Thus, the current data
uggest LPS signaling directly at the endothelium. While
irculating inflammatory mediators certainly can induce
NS cytokines further work is required to implicate these
nd other inflammatory molecules specifically in the blood,
t the endothelium, or in the brain parenchyma.
.2. Predisposition: synaptic loss and cognitive reserve
The interaction between systemic inflammation and prior
egenerative pathology in a particular region provides a
onceptual framework by which we may interrogate aspects
f episodes of delirium induced by systemic inflammation
uring dementia. The prediction, in the current study, of
ysfunction of spatial working memory, as described in
odents by Olton (Olton and Feustle, 1981), was based on
rior pathology in the hippocampus. This pathology is com-
osed of synaptic terminal loss in the stratum radiatum of
A1 with accompanying microglial activation. The vulner-
bility of hippocampal function in this model may be caused
y a loss of “cognitive reserve”. That is to say that there
ay be a threshold below which hippocampal synaptic
ctivity must drop before dysfunction is observed on this
orking memory task. The current data are consistent withhe hypothesis that disease lowers presynaptic input towardhis hypothetical activity threshold and that LPS precipitates
drop in synaptic activity below the threshold and working
emory deficits then appear. It is significant that even 200
g/kg LPS did not induce working memory deficits in
normal animals, suggesting that synaptic loss may be more
important than microglial priming as a predisposing factor,
although obviously exaggerated inflammation also increases
the likelihood of impairments. Given that the cognitive
changes observed were acute onset and relatively rapidly
reversed upon the resolution of inflammation, we propose
that LPS induced acute neurochemical rather than patholog-
ical changes in synaptic activity. It is known that inflam-
matory mediators such as IL-1 can affect electrophysio-
logical aspects of synaptic function (Kelly et al., 2001) and
neurotransmitter release (Taepavarapruk and Song, 2010). It
should be noted that LPS may also cause pathological
changes to presynaptic terminals but we propose that these
are more likely to underpin long term cognitive decline, an
acknowledged consequence of delirium. We have previ-
ously shown that a single systemic LPS challenge can ac-
celerate the progression of the ME7 model of prion disease
(Cunningham et al., 2009a) and altered postsynaptic archi-
tecture has also been reported after LPS challenge in aged
rodents (Richwine et al., 2008). In short, we propose that
microglial priming and synaptic loss constitute significant
risk factors for delirium, and mild systemic inflammation
constitutes a trigger that induces acute cognitive deficits
only when these risk factors are present.
4.3. Can we model delirium in mice?
We propose that these findings are relevant to delirium
during dementia. However, we do not suggest that delirium
in humans is caused by selective hippocampal dysfunction.
Rather, we suggest that systemic inflammation can target
particular brain regions on the basis of existing pathology in
those regions and that the current model allows us to study
these interactions.
Delirium is a heterogeneous syndrome comprising
impairments in attention, orientation, memory, level of
arousal, perception and affect, and psychotic disturbances.
Detecting this full spectrum of dysfunction in a nonverbal
animal such as a mouse is clearly not possible. Thus, we
have focused on a number of key features that are poten-
tially analogous to some core cognitive and temporal fea-
tures of delirium. Firstly episodes are of acute onset and
transient and can be distinguished from chronic cognitive
impairments. Secondly, the interaction of systemic inflam-
mation and existing (Elie et al., 1998; Lerner et al., 1997) or
incipient (Rahkonen et al., 2001) dementia is 1 very com-
mon multifactorial etiological route to clinical delirium and
is mimicked in a biologically relevant way in the current
study. Thirdly, there are similarities in the nature of the
cognitive deficits observed in the T-maze and allocentric
Y-maze and some of those in human delirium: ICD-10
diagnostic criteria include “impairment of recent mem-
614 C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616ory, . . . disorientation for time as well as, in more severe
cases, for place” (World Health Organization, 1992). Ac-
quisition of the allocentric Y-maze task in a novel environ-
ment is impaired in ME7LPS animals (Cunningham et al.,
2009a) but retention performance is not impaired by LPS
when the environment has become familiar after prior train-
ing (Cunningham, unpublished data). Adding the temporal
components required for performance in the working mem-
ory T-maze reveals acute and transient dysfunction even in
a familiar environment. Thus LPS-induced impairments be-
come apparent when processing and retention of novel,
trial-specific information, for just 25 seconds is required to
accurately perform the task. Patients with delirium perform
particularly badly relative to patients with dementia on tasks
requiring retention and processing of novel, trial-specific
information over similar periods (Hart et al., 1996, 1997).
Given the hypothesis that prior pathology is crucial, it is
significant that learning in the egocentric Y-maze, in which
correct responding does not require attention to extramaze
visual cues, was not affected by LPS in ME7 animals (Fig. 2b).
The striatum contributes more significantly to the performance
of egocentric tasks, than does the hippocampus (Cook and
Kesner, 1988; Mitchell and Hall, 1988; White, 1997) and does
not show significant prior pathology in the ME7 model. We
predict that more global pathology, such as that observed in
Alzheimer’s disease (deKosky and Scheff, 1990), would pre-
dict more global cognitive dysfunction upon systemic inflam-
matory insult. Therefore the current model, with good reason,
predicts only a subset of delirium symptoms. Finally, it is
worth noting that spatial working memory alternation tasks,
analogous to those used here, are also acetylcholine dependent
(Bontempi et al., 2003; Givens and Olton, 1995) and prior
studies have modeled delirium by pharmacological disruption
of cholinergic activity (Leavitt et al., 1994; Tamura et al.,
2006). Thus the current hypothesis and hypocholinergic ac-
counts of delirium are not mutually exclusive.
4.4. Concluding remarks
Addressing our limited understanding of delirium patho-
physiology is extremely important both from the point of
view of prevention or treatment of the acute episode, but
also as a means of minimizing the recognized long term
consequences of such episodes. We have now shown that
animals with chronic neurodegeneration, upon systemic in-
flammatory challenge, show acute and transient cognitive
decrements comparable to those described in delirium. Be-
cause this model also shows acceleration of disease post-
LPS (Cunningham et al., 2009a), it is predicted that detailed
examination of the mechanism of inflammatory exacerba-
tion that triggers the acute cognitive changes observed in
this model will have implications for our understanding of
delirium and the role of inflammation in neurodegenerative
disease. These mechanisms are under investigation in our
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Correction strategy in T maze alternation
If animals develop a side preference early in training a
correction strategy can be employed. If animals display a
side preference this can be broken by not allowing them to
self-correct: ie instead of crossing the T from the incorrect
arm to the correct arm, the entrance to the correct arm can
be closed at the moment that the incorrect arm is chosen.
Then animals must return to the start arm and once again
have the option to choose the correct arm. This is repeated
until the animal finally chooses the correct body turn when
starting from the start arm. This correction strategy is only
employed for animals displaying a complete side preference
(ie always turning in one direction if that arm is open to
them), is discontinued once their side preference is broken
and is never employed within 2 days of administration of
substances to examine effects on working memory.
ELISA protocol
Briefly, the capture anti-IL-1, IL-6, and TNF- anti-
bodies were all diluted 1/180 (approximately 1 g/ml) in
BS and used to coat a 96-well maxisorb microplate over-
ight (Nunc; Fisher Scientific, Leicestershire) with 100 l
er well. Plates were then washed with PBS  0.05%
ween and blocked with PBS 1% BSA before addition of
amples, serially diluted as before. Standards were prepared
n the range 8-1000 pg/ml. Detection antibodies were used
t 1/180 in 1% BSA/PBS and Streptavidin poly horseradish
eroxidase was diluted 1:10,000 in high performance
LISA buffer. TMB and H2O2 were used as substrate and
the reaction was stopped with 1M H2SO4 before reading the
ptical density at 450 nm with correction at 570 nm. The
eliable quantification limit of all assays was 15.6 pg/ml.
uantitative RT-PCR
Animals challenged intraperitoneally with saline or LPS
100g/kg) were terminally anaesthetized at 1, 2, 4 or 8
hours post-challenge and then transcardially perfused with
heparinised saline. Brains were rapidly removed and hip-
pocampi punched out, placed in eppendorf tubes, snap fro-
zen on liquid nitrogen and stored at 80 °C until further
use. Total RNA was extracted from brain samples using
Qiagen RNeasy® Plus mini kits (Qiagen, Crawley, UK)
according to the manufacturer’s instructions. Contaminating
genomic DNA was eliminated via degradation during ex-
traction using the Qiagen RNase-free DNase1 enzyme.
ields were determined by spectrophotometry at  260 nm.
NA was stored at 80 °C until cDNA synthesis and PCR
ssay. All equipment and reagents were supplied by Applied
iosystems (Warrington, UK). Primer and probe sequences
or IL-1, IL-6, TNF-, IFN, PTX-3, iNOS, uPAR, CD68,
COX-2 were as previously published (Cunningham et al.,
2005, 2007, 2009, Palin 2008) while those for IL-1R1,
TNFR p55, IFNAR2, TLR4, MCP-1, VCAM1, IRF7,TREM2, and CD200R were designed using the published
sequences for these genes, applied to Primes Express™
software. Where possible, probes were designed to cross an
intron such that they were cDNA specific. Table 1 lists the
sequences for primers and probes for each assay previously
unpublished. In some cases (noted below) the fluorescent
DNA binding probe SYBR green has been used in place of
a specific probe. All primer pairs were checked for speci-
ficity by standard reverse transcription (RT)-PCR followed
by gel electrophoresis and each primer pair produced a
discrete band of the expected amplicon size (supplementary
information). For Taqman PCR, cDNA was generated from
total RNA using a High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems). Two hundred nanograms of
total RNA were reverse transcribed in a 10l reaction vol-
me. One microliter of the RT reaction (equivalent to 20 ng
Figure S1. Rate of learning of correct responding (alternation) in the
shallow water T-maze in ME7 versus NBH animals late or early in disease.
a) Alternation performance of ME7 and NBH animals was examined daily
starting from 18 weeks post-inoculation for four successive days. b) Al-
ternation performance of ME7 and NBH animals was examined daily
starting from 10 weeks post-inoculation for 10 successive days. Data are
shown as mean  SEM and were analysed by repeated measures ANOVA
using training block as the within subjects factor and disease as the
between subjects factor. n  10 for ME7 and n  9 for NBH at 18 weeks
and n  20 for ME7 and n  15 for NBH at 12 weeks.
616.e2 C. Murray et al. / Neurobiology of Aging 33 (2012) 603–616of RNA) was subsequently used for the PCR, as described
previously (Cunningham et al., 2007).
A standard curve was constructed from total RNA iso-
lated from mouse brain tissue 24 hours after intra-cerebral
challenge with 2.5 g LPS, which is known to up-regulate
all target transcripts of interest in this study. This standard
curve was constructed using a higher concentration of RNA
in the reverse transcriptase reaction than that in the samples
for analysis to ensure that the cytokine transcription of all
experimental animal groups will fall within the range of the
standard curve constructed. Serial 1 in 5 dilutions of the
cDNA synthesized from brains of LPS-injected mice
were made and a curve plotted of the Ct value (the cycle
number at which the fluorescence of the product of tran-
Figure S2. Effect of LPS or saline on mRNA expression of inflamma
Transcripts a) TLR4, b) IL-1RI, c) TNFRp55, d) IFNAR2, e) CD68 and
g/kg) or sterile saline. Data are shown as mean  SEM and data wer
(LPS vs saline) as factors for main effects. Results of statistical analys
both NBH groups.scribed gene crosses the threshold of detection) versusthe log of the concentration (assigned an arbitrary value
since the absolute concentration of cytokine transcripts is
not known). Verification that this curve is a straight line
confirms the efficiency of the PCR reaction across the
entire concentration range and the equation of this line can
then be used to calculate the relative concentrations of the
experimental samples. Since the top standard has been as-
signed an arbitrary value, it follows that the calculated
concentrations of all experimental samples will also have
arbitrary values, but these values will be directly related to
the equation of the line.
The housekeeping gene glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) was measured in each sample using
Applied Biosystems Rodent GAPDH Taqman Kit. All PCR
ceptors in ME7 and NBH animals as assessed by quantitative PCR.
M2 were assessed 4 hours post intraperitoneal challenge with LPS (100
sed by two-way ANOVA using disease (ME7 vs NBH) and treatment
resented in full in the text. n  5 for both ME7 groups and n  4 fortory re
f) TRE
e analy
is are pdata were normalised to the expression of GAPDH.
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T-maze alternation in ME7 and NBH animals at 18 weeks
Disease progression in the ME7 model, at 18 weeks,
involves considerable hippocampal neuronal and synaptic
loss. We assessed whether animals at this stage could learn
the T-maze alternation task used elsewhere in this study.
Across 4 blocks of 10 trials NBH animals improved their
performance markedly, while similar improvements were
not made by ME7 animals. These data are shown in figure
S1a. ANOVA revealed a significant effect of treatment (F
9.56, df 1,18, p  0.0063), a significant effect of time (F 
.75. df 3,54, p  0.0006).
NBH and ME7 animals, at 10 weeks post-inoculation
ere trained on the T-maze alternation task for ten blocks of
en trials over two weeks, such that they would reach stable
aseline performance 80% before 12 weeks. This is
hown in figure S1 (bottom panel). ME7 and NBH animals
earned this task at the same rate. There was no effect of
reatment (F  0.13, df 1,34, p  0.7184) but a main effect
f block (F  26.15, df 9,306, p  0.0001). These data are
hown in figure S1b.
ltered expression of inflammatory receptor post-LPS
We assessed whether the panel of cell surface inflamma-
ory receptors assessed in Figure 1 (main text) were further
ltered after treatment with LPS or saline. These data are
hown in figure S2. 0Treatment with LPS induced a decrease in TLR4 mRNA
xpression in both NBH and ME7 animals at 4 hours post-
hallenge. There was a main effect of disease (F  23.3, df
,14, p  0.0003) and of treatment (F  9.75, df 1,14, p 
.0075) but no interaction between these factors.
IL-1RI showed a significant main effect of disease (F 
.68, df 1,14, p  0.048) but no significant main effect of
reatment (F  3.26, df 1,14, p  0.0925) despite slight
ncreases in these transcripts post-LPS. There was also no
ignificant interaction between these factors.
LPS also increased TNFRp55 by approximately 2-fold.
here were main effects of treatment (F  70.14. df 1,13,
 0.0001) and of disease (F  20.42, df 1,13, p  0.0006)
or TNFRp55 but there was no interaction between these
actors (p  0.8968).
IFNAR2 was increased in ME7 with respect to NBH but
as not further increased by LPS. There were main effects
f disease (F  18.21, df 1,14, p  0.0008) but no signif-
cant effect of treatment (ie LPS: F  4.5, df 1,14, p 
.0523). Though LPS did appear to decrease expression of
FNAR2 in ME7 animals, there was no significant interac-
ion between disease and treatment (F  3.29, df 1,14, p 
.09).
Neither CD68 nor TREM2 showed any response to LPS
n either ME7 or NBH animals. There were main effects of
isease in both cases (CD68: F  103.09, df 1,13, p 
.0001 and TREM2: F  136.94, df 1,13, p  0.0001) but
o effect of treatments (CD68: p  0.8190; TREM2: p 
.1898) nor any interaction between these factors.
